Ann Makar
Child & Adolescent Psychiatry · Crestview Hills, KYNPI 1043697162
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 509 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 509 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$866
- Supernus Pharmaceuticals, Inc.$848
- Lundbeck LLC$793
- Otsuka America Pharmaceutical, Inc.$779
- Alkermes, Inc.$676
- Teva Pharmaceuticals USA, Inc.$652
- plus $4K from 19 others
What the payments were for
- Food & beverage$8,384100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 65 | $866 |
| Supernus Pharmaceuticals, Inc. | 51 | $848 |
| Lundbeck LLC | 50 | $793 |
| Otsuka America Pharmaceutical, Inc. | 58 | $779 |
| Alkermes, Inc. | 38 | $676 |
| Teva Pharmaceuticals USA, Inc. | 43 | $652 |
| Johnson & Johnson | 30 | $623 |
| Neurocrine Biosciences, Inc. | 33 | $580 |
| Corium, LLC | 23 | $475 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $426 |
| Almatica Pharma LLC | 13 | $264 |
| Axsome Therapeutics, Inc. | 11 | $236 |
| Vanda Pharmaceuticals Inc. | 10 | $224 |
| Sunovion Pharmaceuticals Inc. | 12 | $205 |
| Ironshore Pharmaceuticals Inc. | 12 | $182 |
| Noven Therapeutics, LLC | 7 | $105 |
| Bausch Health US, LLC | 5 | $98 |
| Avanir Pharmaceuticals, Inc. | 3 | $81 |
| Jazz Pharmaceuticals Inc. | 4 | $71 |
| Tris Pharma Inc | 5 | $69 |
| Alfasigma USA, Inc. | 3 | $59 |
| AbbVie | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,396 in reported general payments places this provider in the 95th percentile of 43 child & adolescent psychiatry providers in Kentucky.
See all child & adolescent psychiatry providers in Kentucky →
Other child & adolescent psychiatry in Crestview Hills
- Julia RoneckerCrestview Hills$2K
- Duncan DarnellPaducah$6K
- Laura MuellerLouisville$4K
- Amber WoodLexington$3K
- Nicole GoodinLexington$3K
- Raquel VasquezLondon$3K
- Justine ChilelliCovington$2K
- Corazon ChuaLouisa$1K
- Michael McIntoshFt Wright$1K
- John GallehrLouisville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.